Effects of a Facial Cream Containing the Minor Alkaloid Anatabine on Improving the Appearance of the Skin in Mild to Moderate Rosacea: An Open-Label Case Series Study
Background: Current medical and scientific research indicates that rosacea, a chronic and often debilitating skin condition that primarily affects the central face, may be caused by an overactive or excessive inflammatory immune response. Regardless of etiology, the accompanying redness and inflamma...
Saved in:
Main Authors: | Ryan K. Lanier (Author), Amy E. Cohen (Author), Susan H. Weinkle (Author) |
---|---|
Format: | Book |
Published: |
Karger Publishers,
2013-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Update on the management of rosacea
by: Weinkle AP, et al.
Published: (2015) -
Systems biology reveals anatabine to be an NRF2 activator
by: Dimitris E. Messinis, et al.
Published: (2022) -
Efficacy and safety of a skin healing cream in mild-to-moderate eczema in a mixed population including infants: An open-label, single-arm study
by: Shilpa Dhar, et al.
Published: (2023) -
Clinical and instrumental evaluation of a new topical non-corticosteroid antifungal/anti-inflammatory/antiseborrheic combination cream for the treatment of mild-to-moderate facial seborrheic dermatitis
by: Dall'Oglio F, et al.
Published: (2019) -
Satisfaction with Control of Mild to Moderate Atopic Dermatitis with Ruxolitinib Cream: US Physician and Patient Perspectives
by: Lawrence F. Eichenfield, et al.
Published: (2024)